NCT00784225View on ClinicalTrials.gov

S0000B: Vitamin E and/or Selenium in Preventing Cataract and Age-Related Macular Degeneration in Men on SELECT SWOG-S0000

PHASE3CompletedINTERVENTIONAL

Enrollment

13,475

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

November 30, 2017

Study Completion Date

May 31, 2018

Conditions

CataractMacular Degeneration

Interventions

DRUG

selenium

200 mcg daily for 7-12 years

DRUG

vitamin E

400 IU daily by mouth for 7-12 years

DRUG

vitamin E placebo

daily for 7-12 years

DRUG

selenium placebo

daily for 7-12 years

Trial Locations (1)

02215

Harvard Medical School, Boston

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

collaborator

National Eye Institute (NEI)

NIH

lead

SWOG Cancer Research Network

NETWORK

NCT00784225 - S0000B: Vitamin E and/or Selenium in Preventing Cataract and Age-Related Macular Degeneration in Men on SELECT SWOG-S0000 | Biotech Hunter | Biotech Hunter